Old Web
English
Sign In
Acemap
>
authorDetail
>
Krishna Kodukula
Krishna Kodukula
Bristol-Myers Squibb
Biochemistry
Diabetes mellitus
Medicine
Neuropeptide Y receptor
IC50
5
Papers
314
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Method for treatment of diabetes, the one-ap2 inhibitor and related combinations used
1999
Jeffrey A. Robl
Rex A. Parker
Scott A. Biller
Haris Jamil
Bruce L. Jacobson
Krishna Kodukula
Show All
Source
Cite
Save
Citations (0)
Procede de traitement de diabetes a l'aide de l'inhibiteur ap2 et combinaison associee
1999
Jeffrey A. Robl
Rex A. Parker
Scott A. Biller
Haris Jamil
Bruce L. Jacobson
Krishna Kodukula
Show All
Source
Cite
Save
Citations (0)
Orevactaene,1 a novel binding inhibitor of HIV-1 rev protein to Rev response element (RRE) from Epicoccum nigrum WC47880
1997
Bioorganic & Medicinal Chemistry Letters
Yue-Zhong Shu
Qingmei Ye
Hui Li
Kathleen F. Kadow
Raouf A. Hussain
Stella Huang
Donald R. Gustavson
Susan E. Lowe
Li-Ping Chang
Dolores M. Pirnik
Krishna Kodukula
Show All
Source
Cite
Save
Citations (35)
BMS-192548, a Tetracyclic Binding Inhibitor of Neuropeptide Y Receptors, from Aspergillus niger WB2346 I.Taxonomy, Fermentation, Isolation and Biological Activity
1995
The Journal of Antibiotics
Krishna Kodukula
Maredith Arcuri
Jingfang Qian-Cutrone
Robert Hugill
Susan E. Lowe
Dolores M. Pirnik
Yue-Zhong Shu
Prabhavathi Fernandes
Ramakrishna Seethala
Show All
Source
Cite
Save
Citations (21)
1